"A 12-week, multicenter, randomized, double-blind, placebo-controlledstudy to assess the efficacy and safety of QAW039 when added tostandard-of-care asthma therapy in patients with uncontrolled asthma"
2020-07-04
عنوان الدراسة
"A 12-week, multicenter, randomized, double-blind, placebo-controlledstudy to assess the efficacy and safety of QAW039 when added tostandard-of-care asthma therapy in patients with uncontrolled asthma"
داعم الدراسة
Novartis
دواء الدراسة
QAW039/Fevipiprant
رقم بروتوكول الدراسة
CQAW039A2316
حالة الدراسة
Ongoing
موقع الدراسة
King Fahad Medical City (Riyadh), King Abdulaziz Medical City NG (Jeddah)
مرحلة الدراسة
3
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。